Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dietary starch and complex carbohydrate are high-molecular-weight polysaccharides, primarily amylose and amylopectin, that serve as the principal source of exogenous glucose for human metabolism (StatPearls, 2023). Found in foods like grains, legumes, and tubers, these molecules undergo enzymatic hydrolysis by salivary and pancreatic alpha-amylase, followed by brush-border alpha-glucosidases, to release glucose for absorption (NIH, 2022). While they are essential nutrients rather than therapeutic targets, their digestion and absorption rates are critical in the pathophysiology of metabolic disorders such as type 2 diabetes and obesity (PubMed, 2021). Drugs like acarbose target the enzymes responsible for starch breakdown rather than the carbohydrates themselves, effectively lowering postprandial blood sugar levels (PubChem, 2024). Additionally, resistant starches that bypass small intestinal digestion play a vital role in colonic health by acting as substrates for short-chain fatty acid production by the gut microbiota (Wikipedia, 2024). The glycemic index of these carbohydrates determines the rate at which they impact blood glucose, making them a central focus of medical nutrition therapy (Mayo Clinic, 2023). Excessive consumption of rapidly digestible starches is associated with increased risk of insulin resistance and cardiovascular disease (American Heart Association, 2022).
Pharmacological intervention typically involves the inhibition of digestive enzymes, such as alpha-amylase and alpha-glucosidase, to delay the hydrolysis of starch into absorbable monosaccharides, thereby reducing postprandial glycemic excursions.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dietary starch and complex carbohydrate.